We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Omnicell
OMCL
$1.72B
| $486K | ﹤0.01% |
10,923
| – | – |
|
1302
Concentrix
CNXC
$1.52B
| $485K | ﹤0.01% |
11,200
-700
| -6% | -$31.1K |
|
1303
RLJ Lodging Trust
RLJ
$1.67B
| $484K | ﹤0.01% |
47,441
+8,500
| +22% | +$82.5K |
|
1304
CoreCivic
CXW
$3.13B
| $483K | ﹤0.01% |
22,200
-9,700
| -30% | -$178K |
|
1305
Cimpress
CMPR
$2.37B
| $480K | ﹤0.01% |
6,696
+400
| +6% | +$31.4K |
|
1306
Fox Factory Holding Corp
FOXF
$886M
| $479K | ﹤0.01% |
15,830
+2,500
| +19% | +$86.1K |
|
1307
Magnite
MGNI
$3.53B
| $479K | ﹤0.01% |
30,100
+6,600
| +28% | +$96.8K |
|
1308
Vishay Intertechnology
VSH
$5.11B
| $479K | ﹤0.01% |
28,297
| – | – |
|
1309
Harmonic Inc
HLIT
$1.42B
| $478K | ﹤0.01% |
36,100
+900
| +3% | +$11.7K |
|
1310
Tennant Co
TNC
$1.15B
| $478K | ﹤0.01% |
5,865
+600
| +11% | +$52.8K |
|
1311
Edgewell Personal Care
EPC
$1.31B
| $477K | ﹤0.01% |
14,202
-2,000
| -12% | -$70.6K |
|
1312
Amer Sports
AS
$19.3B
| $475K | ﹤0.01% |
+17,000
| New | +$375K |
|
1313
Trinity Industries
TRN
$2.34B
| $473K | ﹤0.01% |
13,490
| – | – |
|
|
VRE
1314
DELISTED
Veris Residential
VRE
| $473K | ﹤0.01% |
28,457
| – | – |
|
1315
Huron Consulting
HURN
$2.47B
| $472K | ﹤0.01% |
3,800
| – | – |
|
1316
MillerKnoll
MLKN
$1.62B
| $472K | ﹤0.01% |
20,877
+3,700
| +22% | +$89.4K |
|
1317
Gibraltar Industries
ROCK
$1.45B
| $472K | ﹤0.01% |
8,009
+1,000
| +14% | +$68.2K |
|
1318
NeoGenomics
NEO
$2.11B
| $466K | ﹤0.01% |
28,300
+3,100
| +12% | +$48.1K |
|
1319
Harmony Biosciences
HRMY
$2.24B
| $465K | ﹤0.01% |
13,500
+2,200
| +19% | +$75.6K |
|
1320
Banner Corp
BANR
$2.5B
| $464K | ﹤0.01% |
6,944
| – | – |
|
1321
La-Z-Boy
LZB
$1.67B
| $462K | ﹤0.01% |
10,602
| – | – |
|
1322
Renasant Corp
RNST
$4B
| $462K | ﹤0.01% |
12,923
+2,700
| +26% | +$95.3K |
|
1323
DigitalOcean
DOCN
$15.6B
| $460K | ﹤0.01% |
13,500
+2,400
| +22% | +$94.1K |
|
1324
Seacoast Banking Corp of Florida
SBCF
$3.48B
| $460K | ﹤0.01% |
16,709
+2,000
| +14% | +$56.3K |
|
1325
Stevanato
STVN
$5.88B
| $460K | ﹤0.01% |
21,100
-22,700
| -52% | -$455K |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.